International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Sorafenib Capsules for Pediatric Use

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2019 - Volume 23, Number 5
View All Articles in Issue

Page(s): 411

Sorafenib Capsules for Pediatric Use Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Sorafenib Capsules for Pediatric Use. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: sorafenib, formulation, children, kinase inhibitor, targeted cancer therapy

Related Categories: CANCER AND AIDS, FORMULATIONS, PEDIATRICS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Sorafenib Capsules for Pediatric Use Allen Loyd V Jr	Sep/Oct 2019 Pg. 411
Sorafenib 20-mg/mL in Oil Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 420
Pediatric Compounding: Coloring Outside the Lines Preckshot John	Jan/Feb 2001 Pg. 6-8
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Giacoia George P, Taylor-Zapata Perdita, Mattison Donald	May/Jun 2007 Pg. 220-225
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Corsini Lindsay, Williams LaVonn A	Mar/Apr 2011 Pg. 124-128
Imatinib 40-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 510
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Schotik Debora	Jan/Feb 2001 Pg. 9-12
Compounding for the Pediatric Patient Allen Loyd V Jr	Mar/Apr 1997 Pg. 84-86
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 Giacoia George P, Taylor-Zapata Perdita, Mattison Donald	Jan/Feb 2007 Pg. 5-8
Extemporaneous Formulations in Pediatric Patients Nahata Milap C	Jul/Aug 1999 Pg. 274-276
The Basics of Compounding: Compounding Special Capsules Allen Loyd V Jr	Jul/Aug 1999 Pg. 291-294
Hormonal Influences in Prostate Cancer: An Update of a Complex Subject Biundo Bruce	Mar/Apr 2010 Pg. 100-104
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1 Deleruyelle Laura J	Sep/Oct 2016 Pg. 359-364
Compounding Antiangiogenic Cancer Therapy for Animals Davidson Gigi S	May/Jun 2005 Pg. 195-198
Surviving Cancer - How the Compounding Pharmacist Can Help Maddox Suzan	Jul/Aug 2000 Pg. 257-260
Pediatric Oral Formulations: A Continual Challenge Hurtado Josephine, Moffett Brady S	Jan/Feb 2007 Pg. 17-19
Prescription: Pediatric Formulation Initiatives Allen Loyd V Jr	Nov/Dec 2005 Pg. 410
Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions Fonseca Simonne C	Nov/Dec 2005 Pg. 456-461
Compounding for Pediatric Patients: Case Reports and Formulations Mixon William, Angelle Patricea, Yoch Douglas	Jan/Feb 2009 Pg. 6-12
Compounding for a Pediatric Hospital McElhiney Linda F	Nov/Dec 2005 Pg. 423-431
Return to Top